Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wockhardt BioAg
Zug, Zug, Switzerlandwockhardt.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Wockhardt Bio AG is a Switzerland-based global pharmaceutical and biotechnology company and a key subsidiary of India's Wockhardt Limited. The company is primarily focused on the development, manufacturing, and marketing of pharmaceutical and biopharmaceutical formulations, with a strong emphasis on novel antibiotics to combat antimicrobial resistance (AMR). Its portfolio includes a wide range of generic drugs, biosimilars (such as insulin glargine), and proprietary New Chemical Entities (NCEs) like Zaynich (cefepime/zidebactam) and Miqnaf (nafithromycin). Wockhardt Bio AG manages Wockhardt's international business operations across the US, Europe, the Middle East, and Latin America, utilizing advanced manufacturing facilities in Ireland, the UK, and Dubai.
- Therapeutic areas
- Infectious DiseasesEndocrinology
- Modalities
- Small moleculeBiologicRecombinant proteinPeptides
- Industry
- Pharma
02
Partnerships
Jiangxi Jemincare Group CompanySerum Institute of IndiaEnnoVant
Beyond the preview
Go deeper on Wockhardt BioAg.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wockhardt BioAg.